Neurochemistry and neurotoxicity of substituted amphetamines.
Wagner
J
J
Peroutka
S J
SJ
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000633:toxicity; D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D015198:Designer Drugs; D005277:Fenfluramine / Q000494:pharmacology* / Q000633:toxicity; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D009411:Nerve Endings / Q000378:metabolism; D017374:Paroxetine; D010880:Piperidines / Q000378:metabolism*; D051381:Rats; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism*; D012701:Serotonin / Q000502:physiology
D000662:Amphetamines; D015198:Designer Drugs; D010880:Piperidines; D011985:Receptors, Serotonin; D005277:Fenfluramine; D012701:Serotonin; D017374:Paroxetine; D015104:3,4-Methylenedioxyamphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine